Schizophrenia in Adolescents (add-on medication)

January 06, 2017

Location: Hartford Hospital's Institute of Living

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 12-16 years of age for a 6-week, double-blind, clinical trial with, NaBen, as an add-on treatment study in pediatric and adolescent Schizophrenia.

For more information about this trial, please contact:

Dr. John W. Goethe
Phone: 860.545.7502
Email: [email protected]